- Vedolizumab, sold
under the
brand name
Entyvio, is a
monoclonal antibody medication developed by
Takeda Oncology for the
treatment of
ulcerative colitis...
- spondylitis,
ulcerative colitis monoclonal antibody TNF
antagonist vedolizumab Entyvio ulcerative colitis, Crohn's
disease monoclonal antibody α4β7
integrin blocker...
-
Photodynamic therapy of wet age-related
macular degeneration Tayyaba Hasan, PhD
Entyvio Takeda Treatment of
ulcerative colitis and Crohn's
disease Robert B. Colvin...
-
recommended INN: list 66". WHO Drug Information. 25 (3). hdl:10665/74683. "
Entyvio-
vedolizumab injection, powder, lyophilized, for solution". DailyMed. 3...
-
psoriasis Psoriatic arthritis Crohn's
disease 761044 Link
vedolizumab Entyvio Takeda 5/20/2014
intravenous humanized integrin receptor Ulcerative colitis...
-
Enbrel for
rheumatoid arthritis,
Eloctate and
Alprolix for hemophilia,
Entyvio for crohn's disease, and
total joint replacements such as Durasul, Longevity...
- these,
Tysabri (Biogen Idec/Elan),
Actemra (Hoffmann-La Roche/Chugai),
Entyvio (Millenium Pharma/Takeda) and
Keytruda (Merck/MSD), are
licensed drugs...
